HARVARD BIOSCIENCE INC

HBIO13 Dec 2024
Healthcare
$2.21
-0.01 (-1.34%)
Lowest Today
$2.21
Highest Today
$2.21
Today’s Open
$2.21
Prev. Close
$2.24
52 Week High
$5.56
52 Week Low
$1.99
To Invest in HARVARD BIOSCIENCE INC

HARVARD BIOSCIENCE INC

Healthcare
HBIO13 Dec 2024
-0.01 (-1.34%)
1M
3M
6M
1Y
5Y
Low
$2.21
Day’s Range
High
$2.21
2.21
52 Week Low
$1.99
52-Week Range
52 Week High
$5.56
1.99
1 Day
-
1 Week
-0.88%
1 month return
+3.22%
3 month return
-22.22%
6 month return
-23.02%
1 Year return
-54.65%
3 Years return
-67.58%
5 Years return
-20.56%
10 Years return
-
Institutional Holdings
BlackRock Inc
6.52
Punch & Associates Inv Mgmt Inc
6.36
Harvey Partners LLC
6.22
AMH Equity Ltd
5.48
Harvey Partners Small-Cap Opportunity
5.19
Vanguard Group Inc
4.94
Granahan Investment Management Inc..
4.28

Market Status

Fundamentals
Market Cap
101.19 mln
PB Ratio
1.56
PE Ratio
0
Enterprise Value
143.18 mln
Total Assets
137.37 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.
Organisation
HARVARD BIOSCIENCE INC
Employees
391
Industry
Medical Instruments & Supplies
CEO
Mr. James W. Green
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step